Sharemaestro Newsreel

Park Dental Partners sets Q2FY26 earnings release date

Park Dental Partners, Inc. has announced that it will release its financial results for the second quarter of fiscal year 2026, ending June 30, 2026, after market close on August 12, 2026. The company will also host a conference call on August 13, 2026, …

AdaptHealth sells diabetes unit to Cardinal Health for $235M

AdaptHealth Corp. is selling its Diabetes Health business to Cardinal Health for $235 million in cash, signaling a strategic move to concentrate on its core sleep, respiratory, and home medical equipment operations. This divestiture is part of a multi-year effort to streamline its portfolio …

Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units

Cosmos Health Inc. has expanded its partnership with Pharma Cell for the distribution of its Sky Premium Life brand in Albania, projecting annualized orders to exceed 54,000 units. This expansion builds on a successful partnership launched in April 2025, driven by strong market reception …

Cardinal Health facility near Rickenbacker sells for $49M

A Cardinal Health facility located south of Rickenbacker International Airport in Pickaway County has been sold for $49 million. The transaction was reported by Columbus Business First. Further details regarding the buyer or specific terms were not provided in the preview.

Cencora Inc. stock underperforms Monday when compared to competitors

Cencora Inc. (COR) stock fell by 1.27% on Monday, closing at $303.99. This underperformance occurred on a generally poor trading day where the S&P 500 Index and Dow Jones Industrial Average also saw declines. It marked the second consecutive day of losses for Cencora's …

Henry Schein stock trades steady as dental and medical demand supports earnings outlook

Henry Schein's stock remains stable due to consistent demand from dental and medical practices, supported by growing sales and resilient margins. The company's fiscal 2024 results showed a 2.5% revenue growth to $12.0 billion and increased adjusted earnings per share, driven primarily by its …

UBS Adjusts Price Target on Cardinal Health to $274 From $260, Maintains Buy Rating

UBS has increased its price target for Cardinal Health (CAH) shares to $274 from $260, while reaffirming its Buy rating on the stock. This adjustment suggests a continued positive outlook from the firm regarding Cardinal Health's future performance.

Edwards' Q2 Earnings on the Horizon: What's in the Cards?

Edwards Lifesciences (EW) is set to report its second-quarter 2026 earnings on July 23, with analysts expecting significant revenue and EPS growth driven by strong performance in its TAVR, TMTT, and Surgical Structural Heart segments. The company's prior quarter beat estimates, though its current …

Lobbying Update: $460,000 of CARDINAL HEALTH INC lobbying was just disclosed

Cardinal Health Inc. (CAH) recently disclosed $460,000 in lobbying expenditures for Q2 2026, focusing on issues such as drug pricing, provider reimbursement, and medical supply chain challenges. This filing also details recent insider trading activity, institutional investor movements, analyst ratings, and price targets for …

Leerink Partners Adjusts Price Target on Henry Schein to $88 From $83, Maintains Market Perform Rating

Leerink Partners has raised its price target for Henry Schein to $88 from the previous $83, while maintaining a Market Perform rating on the stock. This adjustment reflects the firm's updated outlook on the medical equipment and supplies distributor. Henry Schein specializes in providing …

Will Henry Schein (HSIC) Beat Estimates Again in Its Next Earnings Report?

Henry Schein (HSIC) is expected to beat its upcoming earnings estimates, continuing a strong trend of exceeding expectations. The company, part of the Zacks Medical - Dental Supplies industry, has a positive Zacks Earnings ESP of +0.41% and a Zacks Rank #2 (Buy), which …

McKesson Corporation (MCK) Stock Analysis: Eyeing an 11.81% Upside with Robust Healthcare Distribution

McKesson Corporation (MCK) is a key player in healthcare distribution with a market cap of $98.51 billion and a diversified business model. Analysts are bullish on MCK, with an average target price suggesting an 11.81% upside, supported by strong revenue growth and financial health. …

International Seaways Inc. $INSW Stock Holdings Boosted by Bessemer Group Inc.

Bessemer Group Inc. significantly increased its stake in International Seaways Inc. (NYSE:INSW) by 45.3% in the first quarter, adding 32,073 shares to reach a total of 102,940 shares valued at approximately $7.5 million. This coincides with strong quarterly earnings reported by International Seaways, including …

Cosmos Health launches subscription model for health products By Investing.com

Cosmos Health Inc. (NASDAQ: COSM) has launched a subscription-based purchasing model for its consumer health brands, starting with NOOR Collagen in the United States. Early results show a more than 60% repeat purchase rate and over 50% margins, significantly improving upon the company's overall …

Cardinal Health stock holds its ground after fiscal 2025 gains

Cardinal Health's stock performance is analyzed based on its fiscal year 2025 results. The company reported revenue of $222.6 billion, adjusted operating earnings of $2.4 billion, and adjusted diluted EPS of $8.03 for the year ending June 30, 2025. These figures highlight the company's …

Cencora stock holds after fiscal 2026 growth update

Cencora's stock movement in fiscal 2026 is driven by its financial performance, with investor focus on revenue, operating profit, and earnings per share given the company's low-margin, high-volume service model. Margin discipline and management guidance are crucial metrics for assessing the value conversion of …

McKesson (MCK) Could Be 11% Undervalued Following Upbeat Earnings Expectations

McKesson (MCK) is currently trading at $841.39, but analysts suggest it may be 10.6% undervalued, with a fair value pegged at $941.40 ahead of its second-quarter earnings report. This positive outlook is driven by increasing adoption of specialty pharmaceuticals and recent acquisitions, which are …

Cencora stock trades steadily as recent earnings highlight solid revenue growth

Cencora Inc. (NYSE: COR) reported robust revenue growth, reaching approximately $68.0 billion, up from $63.0 billion year-over-year, alongside an increase in adjusted EPS from $3.50 to $3.90. The healthcare distributor's steady performance is supported by strong free cash flow, consistent dividend payments, and strategic …

Cardinal Health stock gains as fiscal 2025 revenue reaches $222.6 billion

Cardinal Health's stock is reflecting strong fiscal year 2025 results, with reported revenues of $222.6 billion, operating earnings of $2.7 billion, and diluted EPS of $1.04. The company's large-scale distribution business emphasizes margin discipline over headline growth, operating across pharmaceutical and medical products. These …

Teledyne Technologies Incorporated $TDY Stock Position Trimmed by Heartland Advisors Inc.

Heartland Advisors Inc. reduced its stake in Teledyne Technologies Incorporated (NYSE:TDY) by 16.5% during the first quarter, now holding 41,805 shares valued at $25.29 million. Despite this trim, Teledyne remains Heartland's seventh-largest holding, representing 1.3% of their portfolio. Other institutional investors like Norges Bank …

How McKesson Built Supply Resilience With Automation

McKesson achieved over 99% accuracy in distributing one-third of US prescriptions in FY26 by leveraging an automated, digitally connected infrastructure, advanced cold-chain capabilities, and investing in its workforce's digital skills. The company also focuses on collaboration with thousands of suppliers and providers and has …

How McKesson Cuts Emissions & Increases Renewable Energy Use

McKesson's latest Fiscal Year 2026 Impact Report highlights significant advances in its sustainability initiatives, including achieving 72% of its Scope 1 and Scope 2 emissions reduction target ahead of schedule. The company has also increased its use of renewable energy to 32% across its …

Cosmos Health (COSM) Stock Forecast & Analyst Ratings

This article provides a stock forecast and analyst ratings for Cosmos Health (COSM). It examines various financial metrics and analyst price targets to assess the company's future stock performance.

Henry Schein (HSIC) Baird Global Healthcare Conference 2025 Summary

Henry Schein (HSIC) presented at the Baird Global Healthcare Conference 2025, detailing its strategic initiatives like the BOLD+1 program, recovery from a cyber incident, and value creation projects aimed at improving gross profit and SG&A. The company noted a stable global dental market with …

Henry Schein stock trades steady as recent earnings highlight margin resilience

Henry Schein's stock shows stability following its Q1 2026 earnings report, which highlighted revenue growth and resilient operating margins. The company achieved $3.2 billion in net sales, marking a 6% increase year-over-year, driven by strong demand in dental and medical distribution, and contributions from …

XS3071246378 Bond Profile — Key Metrics

This article provides the key metrics for the Cencora, Inc. 3.625% 22-MAY-2032 bond, identified by XS3071246378, traded on the Stuttgart Stock Exchange. It details the issuer's profile as a pharmaceutical sourcing and distribution services company operating through U.S. and International Healthcare Solutions segments. Key …

Cardinal Health stock trades steadily as recent earnings and dividend support valuation

Cardinal Health's stock remains steady, supported by strong fiscal 2025 earnings and consistent dividend payments, reflecting its role as a major US healthcare distributor. The company focuses on modest revenue growth, margin management, and returning capital to shareholders through dividends and share repurchases. While …

Cencora stock trades steadily as specialty distribution growth supports earnings

Cencora Inc. shows stable performance within the US healthcare distribution sector, reporting revenue growth and solid adjusted earnings due to sustained demand for specialty pharmaceuticals. The company's fiscal Q2 2024 results indicate increased revenue, adjusted diluted EPS growth, and positive guidance for the full …

Cosmos Health repurchases 274,000 shares under buyback program

Cosmos Health Inc. has repurchased an additional 274,000 shares of its common stock at an average price of $0.2554 per share, bringing the total repurchased under its $5 million program to 5,112,000 shares for $1.11 million. Despite the CEO's commitment to the program, citing …

Cardinal Health stock holds gains as revenue grows and margin focus intensifies

Cardinal Health's stock is supported by robust fundamentals, including consistent revenue growth and improved operating margins in both its pharmaceutical and medical product segments. The company reported significant quarterly revenue increases and enhanced diluted EPS, indicating effective translation of top-line growth into profitability despite …

Cardinal Health (CAH) Could Be 7% Undervalued As Specialty Drug Focus Grows

Cardinal Health (CAH) is gaining investor interest due to its increasing focus on specialty pharmaceuticals, with a consensus analyst price target suggesting it's 6.7% undervalued at $245.27. Despite this, its high P/E ratio compared to peers raises questions about potential valuation risk, requiring investors …

McKesson stock trades near record levels as oncology and pharmacy businesses support earnings moment

McKesson's stock is trading near record levels, driven by strong revenue growth, margin expansion, and shareholder returns, particularly from its oncology and pharmacy services. The company's strategic shift to higher-margin clinical and technology services is enhancing profitability and EPS growth, supported by significant share …

Cosmos Health Buys Back 274,000 Shares at About 26 Cents Each

Cosmos Health Inc. (NASDAQ: COSM) announced it repurchased an additional 274,000 shares of its common stock at an average price of approximately $0.2554 per share. This brings the total shares repurchased under its program to 5,112,000 for about $1.11 million, out of an authorized …

Henry Schein stock steady as investors weigh margin trends and dental demand

Henry Schein stock is being analyzed by investors for its balance between robust dental demand and margin pressures stemming from investments and acquisitions. Recent financial reports offer critical data on the company's growth, profitability, and cash generation within the competitive medical and dental distribution …

A1ZW87 Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the A1ZW87 bond issued by Cencora, Inc., which has a coupon rate of 4.25% and matures on March 1, 2045. It details the bond's interest payment overview, including the current coupon rate and the next scheduled payment …

McKesson's Q1 2027 Earnings: What to Expect